Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)
Condition(s):Newly Diagnosed Peripheral T-cell LymphomaLast Updated:August 4, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Newly Diagnosed Peripheral T-cell LymphomaLast Updated:August 4, 2023Recruiting
Condition(s):Peripheral T-Cell LymphomaLast Updated:July 9, 2020Recruiting
Condition(s):Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell LymphomaLast Updated:December 7, 2023Not yet recruiting
Condition(s):Peripheral T-Cell LymphomaLast Updated:December 13, 2023Recruiting
Condition(s):Peripheral T Cell LymphomaLast Updated:January 18, 2017Unknown status
Condition(s):Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeLast Updated:October 10, 2022Recruiting
Condition(s):Peripheral T-cell Lymphoma; Cutaneous T-cell LymphomaLast Updated:July 15, 2021Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:May 11, 2021Recruiting
Condition(s):Cutaneous T Cell Lymphoma; Peripheral T Cell LymphomaLast Updated:August 28, 2023Recruiting
Condition(s):Peripheral T-cell LymphomaLast Updated:December 18, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.